Aaron Newman

Has grant

Assistant Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Aaron Newman is an Assistant Professor at Stanford University in the United States. His research focuses on cancer genomics and immunology, with recent contributions including studies on gene expression from cell-free DNA, the profiling of acral melanoma, and the characteristics of T cells in relation to immune checkpoint blockade toxicity. His work explores critical insights into tumor ecosystems and microenvironments, aiming to enhance understanding and treatment of various cancers.

Recent Grants

Grant: Close

Delineating developmental programs driving tumorigenesis in triple-negative breast cancer

Open Date: 2021-02-01

Close Date: 2026-01-31

Grant: Close

Ultrasensitive Quantitation of Circulating Tumor DNA

Open Date: 2017-08-01

Close Date: 2020-07-31

Grant: Close

Ultrasensitive Quantitation of Circulating Tumor DNA

Open Date: 2015-08-13

Close Date: 2017-07-31

Grant: Close

Genomic Signatures for Integrative Models of Clinical Heterogeneity in Patients with Follicular Lymphoma

Open Date: 2012-09-30

Close Date: 2015-09-29

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aaron Newman

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Inferring gene expression from cell-free DNA fragmentation profiles

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma

Atlas of clinically distinct cell states and ecosystems across human solid tumors

Integrated spatial multiomics reveals fibroblast fate during tissue repair

Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment

Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma

Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer

LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis

Collaborators (8)

Daniel King

Nikita Bedi

Mario Sznol

Arash Ash Alizadeh

Maximilian Diehn

Matthew Vesely

David Kurtz

Mohammad Shahrokh Esfahani

Make your next move.